INTRODUCTION
============

Melioidosis is an emerging infectious disease of major public health concern in southeast Asia. Many cases have been reported from different regions of India but represent only tip of the iceberg as they are mostly reported from few large medical centers, where identification is possible^[@B1]--[@B4]^. In this report, we describe a case series of melioidosis patients presented during 2014 to 2016 in Tamil Nadu.

CASE SERIES
===========

All of them were middle aged men except one case. They were presented with skin, soft tissue, bone and joint infections. All the cases were reported during the monsoon season. Predisposing factors include diabetes and alcoholism. In all the cases, pus culture grew*Burkholderia pseudomallei*. Gram staining of the pus showed Gram-negative bacilli with bipolar staining. The pus culture showed lactose fermenting pink colonies in MacConkey\'s agar on 1st day which turned dry and wrinkled on day 2 ([Figure 1](#F1){ref-type="fig"}). Blood agar showed dry and wrinkled colonies on day 2. The organism was confirmed to be*B. pseudomallei* by the above mentioned culture characteristics and standard biochemical methods (positive oxidase and nitrate reduction test, nonfermentingreaction with triple sugar iron agar, hydrolyse arginine, oxidise glucose and lactose). All the isolates were sensitive to cotrimoxazole, doxycycline, ceftazidime, piperacillin tazobactam and meropenem. Bacteremia was confirmed in three cases. Acute renal injury was the most common organ dysfunction found in all the patients. Three patients died of sepsis due to delayed diagnosis and inappropriate management ([Table 1](#Tab_1){ref-type="table"}).

DISCUSSON
=========

*B. pseudomallei* is an environmental Gram-negative bacterium and etiological agent of melioidosis. It is generally less virulent in healthy hosts but patients with diabetes mellitus, in particular type 2 diabetes, show a high incidence of melioidosis. In Type 1 diabetes mellitus, use of m-cresol (a preservative) with insulin has an inhibitory effect on the organism^[@B5]^. This can be attributed for the high incidence in Type 2 diabetes.

*B. pseudomallei* is known to survive and multiply within cell lines of macrophage/monocyte and neutrophils. Also, the comorbid risk factors for melioidosis contribute by impairing neutrophil function. In diabetes mellitus, neutrophil is structurally and functionally affected thus unable to perform optimally during inflammation. The function still deteriorates during acute and chronic hyperglycemic states. Such type of defects are also observed in association with high alcohol consumption, chronic renal failure and thalassemia. As in tuberculosis, there is a possibility of dormant state of melioidosis in macrophages as there are reported relapses after apparently successful treatment. So, cell mediated immunity plays a prime role in the control of this organism.

![*B. pseudomallei* in MacConkey agar](ijccm-23-149-g001){#F1}

###### 

Demographic details, risk factors and outcome of the cases

                           *Cases*                                                                                                                                                                                                                                                                      
  ------------------------ ---------------------------------------------------- ------------------------ ------------------------------ --------------------------------------------------------------------------- ------------------------------------------ ---------------------------------------- -------------------------
  Age                      52                                                   47                       31                             65                                                                          31                                         46                                       67
  Sex                      M                                                    M                        F                              M                                                                           M                                          M                                        M
  Presenting month         December                                             January                  January                        December                                                                    November                                   September                                October
  Risk factor              DM                                                   DM                       DM                             DM, alcoholism                                                              DM                                         DM, alcoholism                           DM, alcoholism
  Clinical presentation    Elbow and knee arthritis                             Foot cellulitis          Gluteal abscess                Multiple metastatic pyogenic abscess                                        Osteomyelitis with intramuscular abscess   Pyelonephritis, sepsis, knee arthritis   Cellulitis leg, sepsis
  Blood sugar              Recurrent hypoglycemia                               116                      395                            214                                                                         216                                        458                                      372
  Hb                       8                                                    12.2                     8.2                            11.6                                                                        10                                         10.5                                     9.6
  TC                       10,900                                               19,300                   12,200                         17,200                                                                      23,500                                     13,300                                   2200
  ESR                      83                                                   22                       55                             36                                                                          21                                         33                                       39
  Antibiotic sensitivity   S to CAZ, IMI, CIP, COT, CFS                         S to CAZ, COT, DOX       S to CAZ, IMI, MER, CIP, PIT   S to CAZ, MER, IMI, COT, PIT, CIP                                           S to CAZ, PIT, IMI, CIP, COT               S to CAZ, CIP, IMI, PIT                  S to CAZ, CIP, IMI, PIT
  Bacteremia               Absent                                               Absent                   Absent                         Present                                                                     Present                                    Present                                  Absent
  Organ dysfunction        Acute renal injuy, hypoxic ischemic encephalopathy   Raised renal paramters   Nil                            Renal and hepatic dysfunction                                               Renal dysfunction                          Renal and hepatic dysfunction            Acute renal injury
  Treatment                MER, CAZ                                             I & D, CAZ               I & D, PIT                     IMI, I & D of inguinal abscess, splenectomy and drainage of liver abscess   I & D of intramuscular abscess             Imipenem for 2 weeks                     Imipenem started
  Maintenance phase        \-                                                   DOX                      Amoxyclav                      \-                                                                          \-                                         COT                                      
  Outcome                  Died                                                 Recovered                Recovered                      Died                                                                        Died                                       Recovered                                Lost to followup

CAZ: Ceftazidime, IMI: Imipenem, CIP: Ciprofloxacin, COT: Cotrimoxazole, CFS: Cefoperazone Sulbactum, DOX: Doxycycline, MER: Meropenem, PIT: Piperacillin Tazobactum

*B. pseudomallei* is transmitted by inhalation, ingestion and inoculation. There is a strong association with monsoonal rains, and occupational and recreational exposure to surface water. In our centre, all the cases were reported during the monsoon. Cellulitis, arthritis, osteomyelitis, pyelonephritis and abscesses were the clinical presentations. Skin and soft tissue infections were rapidly progressive, mimicking necrotizing fasciitis from other organisms like *Streptococcus* and filamentous fungi. High proportions of patients can present with internal abscess, like in one of our cases, multiple pyogenic abscess with liver and spleen involvement.

Markers of organ dysfunction including leucopenia, elevated liver enzymes, renal parameters and metabolic derangements (hypoglycemia and acidosis) during admission appear to predict mortality. In the present case series, renal dysfunction and metabolic derangements were markers of impending mortality. As the microbiological clearance is slow, repeated positive cultures and persistent radiological abnormalities does not necessarily mean a poor prognosis.

*B. pseudomallei* exhibits resistance to penicillins, amino- glycosides and relatively insensitive to macrolides and flouroquinolones. So, treatment options are limited. Ceftriaxone and cefotaxime use is associated with a higher failure rate among patients with melioidosis^[@B6]^. Ceftazidime and carbapenems remain the drugs of choice during the intensive phase therapy. Use of meropenem especially in severe sepsis is advocated. This is supported by a retrospective study of meropenem use in Australia, in which statistically significant decrease in mortality was seen in meropenem-treated patients with severe sepsis compared with use of ceftazidime only, despite confounding factors like use of Granulocyte colony stimulating factor^[@B7]^. Cotrimoxazole with or without doxycycline is used for the prolonged eradication phase. Doxocycline should not be used as monotherapy as drugresistance is expected^[@B8]^. Adherence to therapy (24-week course of therapy) is the major factor that prevents relapse.

CONCLUSION
==========

To diagnose melioidosis promptly, a high index of suspicion in certain clinical settings cannot be overemphasized. Delayed diagnosis leads way to sepsis and other complications. Awareness about the preventive measures, earlier clinical and laboratory identification, and appropriate management of severe sepsis are required to reduce the burden of this disease.
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